Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hereditary Colon Cancer ACP, October 2013 Steve Lanspa MD, FACP Magnitude of the Problem • Annual worldwide incidence of CRC is 1,023,152*: • • • Lynch syndrome (LS) accounts for 2-5% (20,460-51,160 cases). • • < 1% (10,230 cases) constitute FAP. • • • 20% (204,630 cases) are familial (2 or more firstdegree relatives with CRC. • • Each family is a cancer prevention target! • *International Agency for Research on Cancer. Globocan 2002. Available at: http://www-dep.iarc.fr/. 2 Magnitude All CRC worldwide – Approx 1 million per year LS associated CRC – 21,000 – 50,000 per year JAMA 294:2465-2473, 2005. 4 Two Hit Hypothesis Molecular Changes-Cell Proliferation Two Hit Hypothesis Sporadic Hereditary Normal 1stst Hit X X Mutant X X X X X nd Hit 2nd Tumor XX Tumor Maintenance of DNA integrity Illustration by Jerry Schoendorf, MAMS. Pages 577-587 (February 2006) GE Molecular Classification of CRC • Step-wise accumulations of multiple mutations • Chromosomal Instability (CIN) 85% • Microsatellite Instability (MSI) 5% • CpG island methylator phenotype (CIMP) 10% Chromosomal Instability Pathway (CIN) • Chromosomal gains and losses (aneuploidy; copy number change) • Allele losses (LOH) • Is the molecular basis of progression in CRC in Familial Adenomatous Polyposis Microsatellite Instability Pathway (MSI) • Mononucleotide mutations of tumor suppressor genes • Arises from defective DNA mismatch repair • Is the molecular basis of progression in CRC in Lynch Syndrome Microsatellite Instability (MSI) • Microsatellites (short nucleotide repeats) are prone to replication errors, but corrected by MMR genes in normal cells • In tumor DNA, there are altered lengths (instability) of microsatellites • MSI is a phenotype that can be used as a surrogate for MMR mutation/inactivation (now also IHC for absence of protein expression) • Inactivation of one copy of MMR = 1st hit • Subsequent somatic lesion (2nd hit) leads to mutation rates 1000 times normal CpG Island Methylation (CIMP) • Short stretch of DNA with high CG sequences (phosphodiester bond) • Located at gene promoter • Methylation leads to inactivation of many tumor suppressor genes • ~200 CpG islands that are methylated have been identified in tumor DNA • Epigenetic, biallelic silencing of MLH1 • Tumors highly correlated with a mutation of the BRAF-kinase encoding gene (Chr 7) • May be the molecular basis of progression of CRC in the serrated pathway Familial Adenomatous Polyposis FAP 15 Familial Adenomatous Polyposis Syndrome Oncogenesis - Familial Adenomatous Polyposis Syndrome 212 212 Familial Adenomatous Polyposis Syndrome Oncogenesis Oncogenesis -- Familial Familial Adenomatous Adenomatous Polyposis Polyposis Syndrome Syndrome 213 213 Familial Adenomatous Polyposis Syndrome Oncogenesis - Familial Adenomatous Polyposis Syndrome 215 215 FAP • Germline mutation of APC – Autosomal dominant • Polyps in teens, cancers in 20’s – >100 polyps • Gene testing, colectomy • Surveillance of UGIT • nccn.org Attenuated FAP aFAP Attenuated FAP 21 Later onset (CRC ~age 50) Few colonic adenomas Not associated with CHRPE UGI lesions Associated with mutations at extreme 5’, 3' ends of APC gene, & exon 9A Multiple Adenomatous Polyposis • MAP • Biallelic MUTYH mutation – Autosomal recessive • 10 polyps • CRCS > age 50 years Lynch Syndrome (HNPCC) • H.T. Lynch – Jane Lynch – Patrick Lynch • Creighton University JAMA 2011 Lynch Syndrome associated tumors • • • • • • • Colorectal Endometrial Ovarian Genitourinary Brain Small bowel Hepatobiliary Diagnosing Lynch Syndrome • Amsterdam criteria – 3 relatives with cancer – 2 generations involved – 1 patient under age 50 Yeats • Bethesda criteria – Test familial and synchronous tumors for MSI – MSI+ tumor in a patient under age 60 years • Test all tumors for MSI+ Unique Pathology • Carcinoma of Colon – mucinous carcinomas – signet cell carcinomas – diploid tumors (on flow cytometry) – TILs (tumor infiltrating lymphocytes) • Adenoma – Found in 20% of colons with CRC – Jass and Stewart (Gut 33:783-786, 1992): adenomas in LS were larger, more often villous, and had more high grade dysplasia – Consistent with our hypothesis that adenomas in LS have a greater proclivity for malignant degeneration than sporadic adenomas. Colon Cancer Surveillance in LS • • • • • Adenoma removal is important Surveillance must be at an earlier age and more frequent than that for the general population Colonoscopy to the cecum is important Lesions under 1 cm are important • Would prophylactic subtotal colectomy be better? Do New Technologies Help? • • • • • • • Narrow band imaging colonoscopy Magnifying colonoscopy Chromoendoscopy Autoflorescence CT colography (computer-assisted) MRI colography Chemoprevention Metachronous CRC in LS • Overall incidence 22-41% • Parry al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011;60:950–957. • Cumulative incidence after varying type of resection – Segmental colectomy: 16% – Subtotal colectomy: 2% • de Vos tot Nederveen Cappel et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum. 2002;45:1588–1594. DisColRec 2010 National Comprehensive Cancer Network (http://nccn.org) • Colonoscopy at age 20-25 or 10 years younger than youngest age of cancer Dx • Repeat every 1-2 years • Annual urinalysis with cytology • Endometrial and ovarian cancer screening age 3035; every 6-12 months; TAH-BSO Serrated Polyposis Syndrome • • • • “Hyperplastic polyposis” ? gene, but there is a familial syndrome Associated with pancreatic cancer May have rapid adenoma-carcinoma sequence, similar to LS Peutz-Jeghers Syndrome PJS 42 Peutz-Jeghers Syndrome • Inactivating mutations of tumor suppressor STK gene on chromosome 19p13 • Hyperpigmented macules on buccal mucosa and lips, gastrointestinal (respiratory tract, genitourinary tract) hamartomatous polyps • Increased risk of Gastrointestinal, breast, thyroid lung, pancreatic, uterine cancer, Ovarian sex cord tumors Sertoli cell testicular tumors • Lifelong endoscopic, radiologic (SBS), ultrasound incl. testicular surveillance – ? Role of capsule endoscopy surveillance 43 Summary • • • • • Complete family history High index of suspicion Expert colonoscopy Hereditary Cancer Institute nccn.org